Livia Casciola-Rosen Selected Research

Autoantigens

12/2022	Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis.
1/2022	Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence.
1/2022	The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps.
11/2020	Expression of the Autoantigen Topoisomerase-1 is Enriched in the Lung Tissues of Patients With Autoimmune Interstitial Lung Disease: A Case Control Study.
7/2019	Anti-retinoblastoma Protein Antibodies: A New Specificity in Systemic Lupus Erythematosus Associated With Protection Against Lupus Nephritis.
1/2019	Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in Scleroderma.
10/2018	Brief Report: Anti-Calponin 3 Autoantibodies: A Newly Identified Specificity in Patients With Sjögren's Syndrome.
1/2018	IFI16 filament formation in salivary epithelial cells shapes the anti-IFI16 immune response in Sjögren's syndrome.
11/2016	Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer.
10/2016	Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Livia Casciola-Rosen Research Topics

Disease

28	Dermatomyositis (Dermatopolymyositis) 12/2022 - 09/2002
28	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 09/2002
26	Neoplasms (Cancer) 12/2022 - 10/2003
11	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022 - 06/2009
10	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 10/2003
9	Rheumatic Diseases (Rheumatism) 01/2022 - 07/2008
8	Muscular Diseases (Myopathy) 11/2017 - 09/2010
7	Melanoma (Melanoma, Malignant) 05/2022 - 07/2011
6	Systemic Scleroderma (Systemic Sclerosis) 12/2022 - 07/2002
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2007
3	Deglutition Disorders (Dysphagia) 01/2022 - 11/2017
3	Exanthema (Rash) 05/2021 - 07/2012
3	Rheumatoid Arthritis 01/2021 - 07/2008
3	Calcinosis 12/2017 - 07/2014
3	Polymyositis 06/2016 - 09/2002
3	Arthritis (Polyarthritis) 08/2013 - 06/2009
2	Muscle Weakness 05/2022 - 09/2010
2	Inclusion Body Myositis 01/2022 - 06/2016
2	COVID-19 01/2022 - 10/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2017
2	Pulmonary Hypertension 01/2021 - 01/2004
2	Lupus Nephritis 07/2019 - 12/2015
2	Multiple Sclerosis 10/2018 - 04/2010
2	Skin Diseases (Skin Disease) 01/2018 - 12/2017
2	Edema (Dropsy) 12/2017 - 11/2017
2	Myalgia 12/2017 - 11/2017
2	Inflammation (Inflammations) 11/2017 - 07/2011
2	Fibrosis (Cirrhosis) 11/2017 - 10/2015
2	Gangrene 01/2017 - 01/2016
2	Vascular Diseases (Vascular Disease) 10/2016 - 08/2009
2	Ulcer 05/2015 - 07/2014
2	Antisynthetase syndrome 08/2013 - 06/2009
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Retinoblastoma (Glioblastoma, Retinal) 07/2019
1	Anemia 07/2019
1	Stroke (Strokes) 07/2019
1	Proteinuria 07/2019
1	Thymoma (Thymic Carcinoma) 01/2019
1	Glomerulonephritis 01/2019

Drug/Important Bio-Agent (IBA)

52	AutoantibodiesIBA 12/2022 - 07/2002
30	AntibodiesIBA 12/2022 - 09/2010
20	AutoantigensIBA 12/2022 - 07/2002
11	Proteins (Proteins, Gene)FDA Link 12/2022 - 06/2005
5	RNA Polymerase IIIIBA 01/2019 - 09/2010
4	RNA (Ribonucleic Acid)IBA 12/2022 - 11/2016
4	RNA Polymerase I (Polymerase I, RNA)IBA 12/2022 - 09/2010
4	InterferonsIBA 01/2022 - 10/2012
4	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 09/2010
4	Signal Recognition ParticleIBA 01/2022 - 09/2010
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2009
4	EnzymesIBA 01/2022 - 10/2018
4	AntigensIBA 01/2016 - 02/2005
4	Granzymes (Granzyme)IBA 04/2010 - 07/2002
3	Immunoglobulin M (IgM)IBA 05/2022 - 10/2020
3	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 11/2012
3	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 02/2021 - 09/2010
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2017 - 09/2010
2	nuclear matrix protein 2IBA 12/2022 - 12/2017
2	AngiotensinsIBA 05/2022 - 10/2020
2	tofacitinibIBA 01/2022 - 01/2021
2	ImmunosorbentsIBA 01/2022 - 10/2018
2	transcriptional intermediary factor 1IBA 01/2022 - 07/2014
2	Antinuclear AntibodiesIBA 01/2021 - 09/2015
2	Nucleosomes (Nucleosome)IBA 07/2019 - 10/2018
2	SS-A antibodiesIBA 01/2019 - 12/2015
2	Nuclear Matrix-Associated ProteinsIBA 10/2018 - 11/2013
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 10/2018 - 02/2011
2	anti-RNA-polymerase III autoantibodyIBA 01/2018 - 11/2015
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017 - 11/2012
2	Biological ProductsIBA 04/2015 - 12/2004
2	IFIH1 Interferon-Induced HelicaseIBA 08/2013 - 07/2012
2	Ligases (Synthetase)IBA 07/2011 - 09/2002
2	Transfer RNA (tRNA)IBA 07/2011 - 09/2002
2	NucleophosminIBA 01/2004 - 10/2003
1	Methylprednisolone FDA LinkGeneric 05/2022
1	Nucleic AcidsIBA 01/2022
1	Mi-2 antibodiesIBA 01/2022
1	imidazole mustard (BIC)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Coenzyme A (CoA)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	CortactinIBA 01/2022
1	UbiquitinIBA 05/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 07/2019
1	Antiphospholipid AntibodiesIBA 07/2019
1	HeterochromatinIBA 07/2019
1	ChromatinIBA 07/2019
1	Retinoblastoma ProteinIBA 07/2019

Therapy/Procedure

5	Therapeutics 01/2018 - 09/2010
1	Immunomodulation 07/2022
1	Precision Medicine 12/2021